JPMORGAN CHASE & CO - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W909. A total of 4 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$5,946,000
+83.6%
257,500
+12.0%
0.00%0.0%
Q3 2020$3,238,000
+33.3%
230,000
+42.8%
0.00%
Q2 2020$2,429,000
+1145.6%
161,100
+663.5%
0.00%
Q1 2020$195,000
-50.0%
21,100
-47.2%
0.00%
Q4 2019$390,000
-18.8%
40,0000.0%0.00%
Q2 2019$480,000
-87.8%
40,000
-86.2%
0.00%
-100.0%
Q1 2019$3,944,000
-40.7%
290,000
-47.3%
0.00%0.0%
Q3 2018$6,650,000
+77.4%
550,000
+129.2%
0.00%0.0%
Q2 2018$3,749,000
+176.9%
240,000
+166.7%
0.00%
Q1 2018$1,354,000
-5.9%
90,000
-10.0%
0.00%
Q4 2017$1,439,000
+257.1%
100,000
+150.0%
0.00%
Q2 2017$403,000
+5.5%
40,000
-42.9%
0.00%
Q2 2016$382,00070,0000.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 2,020$4,664,0000.01%
GROUP ONE TRADING, L.P. 123,700$2,856,0000.01%
JPMORGAN CHASE & CO 257,500$5,946,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of AMICUS THERAPEUTICS INC shareholders